Reversible Contraception in Males: An Obtainable Target?

Biology (Basel). 2024 Apr 25;13(5):291. doi: 10.3390/biology13050291.

Abstract

The last few decades have brought contraception to the forefront of research, with great strides made in effectively targeting and optimizing the physiology, pharmacology, and delivery processes that prevent pregnancy. However, these advances still predominantly target female contraceptives for the prevention of contraception, whereas targeting the male sex has lagged far behind. This has led to a marked deficiency in safe and effective male contraceptive agents, resulting in a heavy dependence on female contraceptives to prevent unwanted and unplanned pregnancies. Current research in the veterinary field and in rodents highlights several promising avenues whereby novel, safe, and effective male contraceptive alternatives are being developed-with an emphasis on reduced side effects and reversibility potential. This review aims to discuss current and novel male contraceptives (both human and veterinary formulations) while highlighting their efficacy, advantages, and disadvantages.

Keywords: One Health; comparative medicine; hormonal; human; male contraception; nonhormonal; reproduction; sex hormones; triptonide; veterinary.

Publication types

  • Review

Grants and funding

The authors gratefully acknowledge the funding sources NIH and the Oklahoma Center for the Advancement of Science and Technology (OCAST), including NIA K01-AG064121 (Butcher) and OCAST HR21-045-1 (Butcher).